Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 C.R. Bard Snaps Up Medivance for $250 million - Medical Product Outsourcing

C.R. Bard Snaps Up Medivance for $250 million

New acquisition provides therapeutic body temperature control.

C. R. Bard Inc. will acquire Medivance Inc. for $250 million.

Once the transaction is completed, Medivance will become part of the firm’s Bard Medical division.

Medivance, based in Louisville, Colo., offers medical technology in the field of therapeutic hypothermia. Accurate manipulation of body temperature is used for a variety of critically ill patients.

Medivance is a good fit in C.R. Bard’s critical care business and their technology addresses a large unmet need in a market that’s growing double digits, Bard CEO Timothy M. Ring said in a statement.

Based on the anticipated completion of the merger in the fourth quarter, Bard expects the dilution impact to be immaterial to earnings per share in 2011.

Bard, headquartered in Murray Hill, N.J., provides medical technologies in the fields of vascular, urology, oncology and surgical specialty products.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters